Filters
reset allOther countries
Results: 1 to 20 of 20
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Invitae Nuclear Mitochondrial Disorders Panel Invitae United States | 394 | 319 |
|
Invitae Supplemental Metabolic Newborn Screening Panel Invitae United States | 253 | 189 |
|
Invitae Comprehensive Neurometabolic Disorders Panel Invitae United States | 351 | 249 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
NGLY1 - Congenital disorder of glycosylation type IV Translational Metabolic Laboratory Radboud University Medical Centre Netherlands | 1 | 1 |
|
Congenital Disorders of Glycosylation (CDG) Panel PreventionGenetics, part of Exact Sciences United States | 56 | 54 |
|
Invitae Congenital Disorders of Glycosylation Panel Invitae United States | 203 | 152 |
|
Early Infantile Epileptic Encephalopathy Panel PreventionGenetics, part of Exact Sciences United States | 144 | 124 |
|
Glycogen Storage Disease and Disorders of Glucose Metabolism Panel PreventionGenetics, part of Exact Sciences United States | 33 | 33 |
|
Integrated Genetics Westborough LabCorp United States | 330 | 746 |
|
Integrated Genetics Westborough LabCorp United States | 292 | 597 |
|
Integrated Genetics Westborough LabCorp United States | 330 | 746 |
|
Integrated Genetics Westborough LabCorp United States | 287 | 578 |
|
Panel of congenital disorders of glycosylation. NGS panel of 47 genes. Genologica Medica Spain | 55 | 47 |
|
Comprehensive Metabolism Panel Blueprint Genetics Finland | 14 | 434 |
|
Invitae Rett and Angelman Syndromes and Related Disorders Panel Invitae United States | 28 | 22 |
|
Asper Biogene Asper Biogene LLC Estonia | 210 | 204 |
|
Congenital Disorders of Glycosylation (CDG) Panel CeGaT GmbH Germany | 20 | 34 |
|
Congenital Disorders of Glycosylation (CDG) Panel CeGaT GmbH Germany | 20 | 34 |
|
Results: 1 to 20 of 20
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.